Research & Publications †
( † Disclaimer: This search is powered by PubMed, a service of the U.S. National Library of Medicine. PubMed is a third-party website with no affiliation with Cleveland Clinic.)
Thomas Santoscoy, MD, is the Attending Surgeon in the Department of Cardiothoracic Surgery at Hillcrest Hospital. He has a special interest in surgical treatment of adult acquired heart disease and thoracic surgery. Dr. Santoscoy is certified by the American Board of Thoracic Surgery and the American Board of Surgery.
Dr. Santoscoy received his medical degree at the University of Kansas School of Medicine after graduating from the University of Texas at El Paso. After completing residencies in general surgery and in cardiovascular and thoracic surgery at Cleveland Clinic, he spent one year in the Department of Cardiovascular Surgery at Mayo Graduate School of Medicine as a Fellow in Congenital and Acquired Heart Disease.
Dr. Santoscoy is active in the community, currently serving on the board of Esperanza, Inc. He is a former Board Member of Providence House. His publications include articles on the surgical management of portal hypertension and esophageal varices and accuracy of carotid compression tomography in the diagnosis of carotid artery stenosis.
Dr. Santoscoy is a Fellow in the American College of Surgeons and in the American College of Cardiology. He is also a member of the Cleveland Surgical Society, the Cleveland Academy of Medicine, the Ohio State Medical Association, the Society of Thoracic Surgeons and the American College of Chest Physicians.
surgical treatment of adult acquired heart disease, thoracic surgery
Cleveland Clinic physicians and scientists may collaborate with the pharmaceutical or medical device industries to help develop medical breakthroughs or provide medical expertise or education. Cleveland Clinic strives to make scientific advances that will benefit patient care and support outside relationships that promise public benefit. In order for the discoveries of Cleveland Clinic physicians' and scientists' laboratories and investigations to benefit the public, these discoveries must be commercialized in partnership with industry. As experts in their fields, Cleveland Clinic physicians and scientists are often sought after by industry to consult, provide expertise and education.
To assure professional and commercial integrity in such matters, Cleveland Clinic maintains a program that reviews these collaborations and, when appropriate, puts measures in place to minimize bias that may result from ties to industry. Cleveland Clinic publicly discloses the names of companies when (i) its physicians/scientists receive $5,000 or more per year (or, in rare cases, equity or stock options) for speaking and consulting, (ii) its physicians/scientists serve as a fiduciary, (iii) its physicians/scientists
receive or have the right to receive royalties or (iv) its physicians/scientists hold any equity interest for the physician's/scientist's role as inventor, discoverer, developer, founder or consultant.* In publicly disclosing this information, Cleveland Clinic tries to provide information as accurately as possible about its physicians' and scientists' connections with industry.
As of 4/29/2016, Dr. Santoscoy has reported no financial relationship with industry that is applicable to this listing. In general, patients should feel free to contact their doctor about any of the relationships and how the relationships are overseen by Cleveland Clinic. To learn more about Cleveland Clinic's policies on collaborations with industry and innovation management, go to our Integrity in Innovation page.
Public Health Service-Reportable Financial Conflicts of Interest. Cleveland Clinic scientists and physicians engage in basic, translational and clinical research activities, working to solve health problems, enhance patient care and improve quality of life for patients. Interactions with industry are essential to bringing the researchers’ discoveries to the public, but can present the potential for conflicts of interest related to their research activities. Click here to view a listing of instances where Cleveland Clinic has identified a Public Health Service (PHS)-Reportable Financial Conflict of Interest and has put measures in place to ensure that, to the extent possible, the design, conduct and reporting of the research is free from bias. * Cleveland Clinic physicians and scientists subscribe to the guidance presented in the PhRMA Code on Interactions with Healthcare Professionals and the AdvaMed Code of Ethics on Interactions with Health Care Professionals. As such, gifts of substantial value are generally prohibited.